|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.66 CNY | -5.03% |
|
-22.68% | -52.36% |
Dali Pharmaceuticalco.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 69.68 million compared to CNY 92.05 million a year ago. Net loss was CNY 8.49 million compared to CNY 1.17 million a year ago.
Basic loss per share from continuing operations was CNY 0.0386 compared to CNY 0.0053 a year ago. Diluted loss per share from continuing operations was CNY 0.0386 compared to CNY 0.0053 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -52.36% | 172M | |
| +19.62% | 43.27B | |
| +24.52% | 22.92B | |
| +20.29% | 15.43B | |
| +7.48% | 12.95B | |
| +42.51% | 11.83B | |
| -8.84% | 6.91B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.55B |
DALI PHARMACEUTICALCO.,LTD 
